Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes.
Candoni
A
A
Raza
A
A
Silvestri
F
F
Lisak
L
L
Galili
N
N
Mumtaz
M
M
Kikic
F
F
Fanin
R
R
D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000401:mortality*; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013792:Thalidomide